Morepen Labs zooms 8% on USFDA nod to market anti-allergy drug 0 06.12.2021 09:42 Economictimes.indiatimes.com The US FDA approval provides an imminent boost to Morepen’s export business as Fexofenadine is a well-established anti-allergy drug boasting a market share of 700 MT. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
